Sodium iodide
- Generic Name
- Sodium iodide
- Brand Names
- Sclerodine
- Drug Type
- Small Molecule
- Chemical Formula
- INa
- CAS Number
- 7681-82-5
- Unique Ingredient Identifier
- F5WR8N145C
- Background
Sodium iodide is a water-soluble ionic compound with a crystal lattice. Sodium iodide is a source of iodine and can be administered as a supplement for total parenteral nutrition but is more commonly used in veterinary medicine. Radiolabelled compound, Iodide I-131, is used as a diagnostic tool to evaluate thyroid function and morphology.
- Indication
Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN) .
- Associated Conditions
- Abscesses, Bleeding of the Vitreal Body, Clouding of the Lenses, Vitreous opacities, Wound
- Associated Therapies
- Total parenteral nutrition therapy
Evaluation in STEMI Patients Using FDY-5301
- Conditions
- STEMIPercutaneous Coronary RevascularizationAcute Myocardial Infarction
- Interventions
- Other: Placebo
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Faraday Pharmaceuticals, Inc.
- Target Recruit Count
- 2351
- Registration Number
- NCT04837001
- Locations
- 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸Lehigh Valley Hospital, Allentown, Pennsylvania, United States
🇺🇸Allina Health System, Minneapolis, Minnesota, United States
Evaluation of FDY-5301 in Major Trauma Patients in ICU
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Faraday Pharmaceuticals, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT04430283
- Locations
- 🇺🇸
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States
🇺🇸Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸Harborview, Seattle, Washington, United States
A Study of Acute Myocardial Infarction Using FDY-5301
- First Posted Date
- 2018-03-20
- Last Posted Date
- 2021-12-14
- Lead Sponsor
- Faraday Pharmaceuticals, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT03470441
- Locations
- ðŸ‡ðŸ‡º
Budai Irgalmasrendi Kórház, Budapest, Hungary
ðŸ‡ðŸ‡ºMagyar Honvédség Egészségügyi Központ, Budapest, Hungary
ðŸ‡ðŸ‡ºBorsod-Abaúj-Zemplén Megyei Központi Kórház, Miskolc, Hungary
A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years
- Conditions
- Transient Hypothyroxinemia
- Interventions
- First Posted Date
- 2008-03-18
- Last Posted Date
- 2015-05-18
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 1275
- Registration Number
- NCT00638092
- Locations
- 🇬🇧
Ninewells Hospital and Medical School, Dundee, Tayside, United Kingdom
🇬🇧Royal Maternity Hospital, Belfast, United Kingdom
🇬🇧Heartlands Hospital, Birmingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.